Accure
3 known investors
Find your way into Accure
1,433 people in our graph share verified history with the Accure team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Pablo Villoslada · together at Stanford University (overlapped)
×4knows the team · via Stanford University
×2knows the team · via UCSF
knows the team · via F. Hoffmann-La Roche
knows the team · via Bionure
×3knows the team · via emlyon business school
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
Founders & leadership
LN
Laurent NguyeninCEOHe brings experience across pharmaceutical development, commercialization, and business development, including prior roles in pharma marketing, sales, acquisitions, and medical practice.
PV
Pablo VillosladainCSOPablo Villoslada is a neurologist with over 20 years of experience in translational medicine across academia, biotech, medical devices, and pharmaceutical settings, with expertise spanning drug development (small molecules and cell therapy), clinical trial design and execution through Phase III, regulatory submissions, medical devices including neurostimulation, and digital health applications.
RM
Rossella MedoriinCMO
PB
Paul BikardinCFOHe has CFO experience in the biotechnology industry across companies of various stages.
Investors · 3
Competitors · 5
by search overlap
Robinhood6 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Acurx Pharmaceuticals6 shared keywordsAcurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
Simply Wall St6 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Seeking Alpha5 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Accure for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Accure do?
- Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
- Who are Accure's investors?
- Accure's investors include Aliath Bioventures, Asabys Partners, Kinled Holding.